Results 11 to 20 of about 831 (142)

Evaluation of anti-tumour properties of two depsidones – Unguinol and Aspergillusidone D – in triple-negative MDA-MB-231 breast tumour cells [PDF]

open access: yesToxicology Reports, 2019
There is an ongoing search for new compounds to lower the mortality and recurrence of breast cancer, especially triple-negative breast cancer. Naturally occurring depsidones, extracted from the fungus Aspergillus, are known for their wide range of ...
Majorie B.M. van Duursen   +1 more
exaly   +5 more sources

Lichen-Derived Bioactive Compounds in Diabetes and Cardiovascular Risk: Experimental Evidence, Mechanisms, and Translational Challenges [PDF]

open access: yesBiomedicines
Cardiometabolic disorders arise from interconnected metabolic, inflammatory, oxidative, mitochondrial, and vascular abnormalities. Lichens produce structurally diverse secondary metabolites, including depsides, depsidones, dibenzofurans, anthraquinones ...
Alfredo Torres-Benítez   +9 more
doaj   +2 more sources

Penicillides from Penicillium and Talaromyces: Chemical Structures, Occurrence and Bioactivities [PDF]

open access: yesMolecules
Penicillide is the founder product of a class of natural products of fungal origin. Although this compound and its analogues have been identified from taxonomically heterogeneous fungi, they are most frequently and typically reported from the species of ...
Maria Michela Salvatore   +3 more
doaj   +2 more sources

Brominated Depsidones with Antibacterial Effects from a Deep-Sea-Derived Fungus Spiromastix sp. [PDF]

open access: yesMarine Drugs
Eleven new brominated depsidones, namely spiromastixones U-Z5 (1–11) along with five known analogues (12–16), were isolated from a deep-sea-derived fungus Spiromastix sp. through the addition of sodium bromide during fermentation.
Zequan Huang   +7 more
doaj   +2 more sources

Extraction of lichen bioactive compounds using volatile natural deep eutectic solvents and comparative analytical approaches [PDF]

open access: yesScientific Reports
Lichens are a source of bioactive secondary metabolites with different pharmacological activities. However, these metabolites are challenging regarding their extraction.
S. Dresler   +9 more
doaj   +2 more sources

Unveiling the therapeutic potential of Lobaria extract and its depsides/depsidones in combatting Aβ42 peptides aggregation and neurotoxicity in Alzheimer’s disease [PDF]

open access: yesFrontiers in Pharmacology
Background: The development of effective inhibitors that can inhibit amyloid β (Aβ) peptides aggregation and promote neurite outgrowth is crucial for the possible treatment of Alzheimer’s disease (AD).
Meixia Yang   +15 more
doaj   +2 more sources

Lichen Depsides and Depsidones Reduce Symptoms of Diseases Caused by Tobacco Mosaic Virus (TMV) in Tobacco Leaves

open access: yesNatural Product Communications, 2012
Two depsides and five depsidones, isolated from lichens, were tested to determine their in vivo protective effects on tobacco leaves challenged with Tobacco Mosaic Virus (TMV).
Luis Espinoza   +2 more
exaly   +2 more sources

Theoretical Study on the Antioxidant Activity of Natural Depsidones

open access: yesACS Omega, 2020
Depsidones are secondary metabolites in lichens with a range of potential health benefits. Among others, these compounds are believed to exhibit high hydroxyl radical and superoxide scavenging abilities, warranting a detailed investigation of their ...
Mai Van Bay   +6 more
doaj   +2 more sources

Two New Fumarprotocetraric Acid Lactones Identified and Characterized by UHPLC-PDA/ESI/ORBITRAP/MS/MS from the Antarctic Lichen Cladonia metacorallifera

open access: yesSeparations, 2022
Lichens are symbiotic organisms between algae and fungi, which are makers of secondary compounds named as lichen substances. Hyphenated techniques have significantly helped natural product chemistry, especially UHPLC/ESI/MS/MS in the identification ...
Beatriz Sepúlveda   +4 more
doaj   +1 more source

Structure-Based Virtual Screening and Molecular Dynamics Simulation Assessments of Depsidones as Possible Selective Cannabinoid Receptor Type 2 Agonists

open access: yesMolecules, 2023
The discovery of natural drug metabolites is a leading contributor to fulfilling the sustainable development goal of finding solutions to global health challenges.
Gamal A. Mohamed   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy